Order Article Reprints

Nishimura T, Fujimoto H, Fujiwara T, Ito K, Fujiwara A, Yuda H, Itani H, Naito M, Kodama S, Yagi A, et al. Efficacy and Safety of Amrubicin in Small Cell Carcinoma Previously Treated with Immune Checkpoint Inhibitors and Chemotherapy. Cancers. 2022; 14(16):3953. https://doi.org/10.3390/cancers14163953

Nishimura, Tadashi, Hajime Fujimoto, Takumi Fujiwara, Kentaro Ito, Atsushi Fujiwara, Hisamichi Yuda, Hidetoshi Itani, Masahiro Naito, Shuji Kodama, Akihiko Yagi, and et al. 2022. "Efficacy and Safety of Amrubicin in Small Cell Carcinoma Previously Treated with Immune Checkpoint Inhibitors and Chemotherapy" Cancers 14, no. 16: 3953. https://doi.org/10.3390/cancers14163953

Nishimura, T., Fujimoto, H., Fujiwara, T., Ito, K., Fujiwara, A., Yuda, H., Itani, H., Naito, M., Kodama, S., Yagi, A., D’Alessandro, V. F., Yasuma, T., Furuhashi, K., Saiki, H., Okano, T., Tomaru, A., Tanigawa, M., D’Alessandro-Gabazza, C. N., Gabazza, E. C., ... Kobayashi, T. (2022). Efficacy and Safety of Amrubicin in Small Cell Carcinoma Previously Treated with Immune Checkpoint Inhibitors and Chemotherapy. Cancers, 14(16), 3953. https://doi.org/10.3390/cancers14163953